Mmegi

Pharmaceuticals present $190m opportunity for growth, innovation

Shot in the arm: The COVID-19 pandemic exposed the need for countries such as Botswana to bulk up their pharmaceutical sectors PIC:  VCU NEWS
Shot in the arm: The COVID-19 pandemic exposed the need for countries such as Botswana to bulk up their pharmaceutical sectors PIC: VCU NEWS

A study into the potential of developing a pharmaceutical industry in the country has found that strategic investments in policy, skills development, and harnessing the country’s rich biodiversity, could transform the infant sector into a regional powerhouse.

The study was developed last year by the Botswana Investment and Trade Centre (BITC) in partnership with the European Union’s Africa RISE (Reform for Investment and Sustainable Economies) programme.

The study aims to help Botswana develop its pharmaceutical manufacturing capabilities while boosting its competitiveness at both local and regional levels. The consultancy team included three local experts from the University of Botswana who worked alongside the BITC team, reporting to a diverse reference group that validated the findings.

Editor's Comment
Consult, get buy-ins first for 6 to 6 policy, Hon Minister

While the minister is of the view that the proposal would have significant positive economic impact, the entertainment industry players believe otherwise. The issue has over the weeks become a hot potato. But what is of essence right now is that the country needs liberal ideas to move in the right direction While opening up the economy may sound quite interesting to the ear, rolling out extended trading hours through pilot programmes without...

Have a Story? Send Us a tip
arrow up